First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2011-01-27 10:31:34Open Document File Size: 39,38 KBShare Result on FacebookCityWINSTON-SALEM / /CompanyDignitana AB / Wake Forest Baptist / /ContinentAmerica / Europe / /CountryJapan / United States / Canada / / /EventFDA Phase / Business Partnership / /FacilityNorth Carolina Baptist Hospital / Wake Forest University / Wake Forest University Baptist Medical Center / Brenner Children’s Hospital / University of California / /IndustryTermscalp cooling device / therapy for cancer / /MedicalConditioncancer / breast cancer / /MedicalTreatmentChemotherapy / /OrganizationBrenner Children’s Hospital / Wake Forest University / Wake Forest University Baptist Medical Center / FDA / University of California / San Francisco / School of Medicine and Piedmont Triad Research Park / North Carolina Baptist Hospital / /PersonSusan Melin / Martin Waleij / Yvonne Olofsson / Bonnie Davis / / /Positionprincipal investigator for the study / oncology nurse / CEO / associate professor of Internal Medicine-Hematology and Oncology / chief executive officer / Media Relations Manager / associate professor / /ProductTriad / DigniCap™ / /ProvinceOrStateNorth Carolina / California / /PublishedMediumU.S. News & World Report / /TechnologyChemotherapy / /URLwww.wfubmc.edu / http /SocialTag |